Follow
June Tordoff
Title
Cited by
Cited by
Year
A systematic review and meta‐analysis of pharmacist‐led fee‐for‐services medication review
E Hatah, R Braund, J Tordoff, SB Duffull
British journal of clinical pharmacology 77 (1), 102-115, 2014
2372014
Challenges and enablers of deprescribing: a general practitioner perspective
NJ Ailabouni, PS Nishtala, D Mangin, JM Tordoff
PloS one 11 (4), e0151066, 2016
2052016
Medicine-taking practices in community-dwelling people aged≥ 75 years in New Zealand
JM Tordoff, ML Bagge, AR Gray, AJ Campbell, PT Norris
Age and Ageing 39 (5), 574-580, 2010
1052010
Continuation of proton pump inhibitors from hospital to community
K Grant, N Al-Adhami, J Tordoff, J Livesey, G Barbezat, D Reith
Pharmacy World and Science 28, 189-193, 2006
882006
“It’s just routine.” A qualitative study of medicine-taking amongst older people in New Zealand
J Tordoff, K Simonsen, WM Thomson, PT Norris
Pharmacy world & science 32, 154-161, 2010
842010
Potentially inappropriate medicines in a cohort of community‐dwelling older people in N ew Z ealand
PS Nishtala, ML Bagge, AJ Campbell, JM Tordoff
Geriatrics & gerontology international 14 (1), 89-93, 2014
732014
General practitioners’ perceptions of pharmacists’ new services in New Zealand
E Hatah, R Braund, S Duffull, J Tordoff
International journal of clinical pharmacy 34, 364-373, 2012
732012
General practitioners’ insight into deprescribing for the multimorbid older individual: a qualitative study
NJ Ailabouni, PS Nishtala, D Mangin, JM Tordoff
International Journal of Clinical Practice 70 (3), 261-276, 2016
702016
Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008
E Lee, R Braund, J Tordoff
The New Zealand Medical Journal (Online) 122 (1293), 2009
702009
‘What do patients want?’Tailoring medicines information to meet patients' needs
A Young, J Tordoff, A Smith
Research in Social and Administrative Pharmacy 13 (6), 1186-1190, 2017
672017
Non-medical prescribing in New Zealand: an overview of prescribing rights, service delivery models and training
R Raghunandan, J Tordoff, A Smith
Therapeutic advances in drug safety 8 (11), 349-360, 2017
502017
A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand
R Ragupathy, K Aaltonen, J Tordoff, P Norris, D Reith
Pharmacoeconomics 30, 1051-1065, 2012
502012
Impact of prescription charges on people living in poverty: a qualitative study
P Norris, J Tordoff, B McIntosh, K Laxman, SY Chang, L Te Karu
Research in Social and Administrative Pharmacy 12 (6), 893-902, 2016
452016
Effect of the pediatric exclusivity provision on children's access to medicines
J Grieve, J Tordoff, D Reith, P Norris
British journal of clinical pharmacology 59 (6), 730-735, 2005
452005
Changes in availability of paediatric medicines in Australia between 1998 and 2002
J Chui, J Tordoff, D Reith
British journal of clinical pharmacology 59 (6), 736-742, 2005
442005
Trends in accessibility to medicines for children in New Zealand: 1998–2002
J Chui, J Tordoff, J Kennedy, D Reith
British journal of clinical pharmacology 57 (3), 322-327, 2004
442004
Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998–2002
K Balakrishnan, J Tordoff, P Norris, D Reith
British journal of clinical pharmacology 63 (1), 85-91, 2007
402007
The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand
K Aaltonen, R Ragupathy, J Tordoff, D Reith, P Norris
Value in Health 13 (1), 148-156, 2010
392010
Older people’s attitudes towards their regular medicines
M Bagge, J Tordoff, P Norris, S Heydon
Journal of primary health care 5 (3), 234-242, 2013
382013
Older people's experiences of medicine changes on leaving hospital
M Bagge, P Norris, S Heydon, J Tordoff
Research in Social and Administrative Pharmacy 10 (5), 791-800, 2014
372014
The system can't perform the operation now. Try again later.
Articles 1–20